niacinamide has been researched along with rhodamine 123 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, MR; Li, AM; Lü, CW; Luo, RC; Su, N; Wei, L; Yan, X; Zheng, DY | 1 |
| Bernkop-Schnürch, A; Islambulchilar, Z; Laffleur, F; Shahnaz, G | 1 |
2 other study(ies) available for niacinamide and rhodamine 123
| Article | Year |
|---|---|
[Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Exocytosis; Flow Cytometry; Humans; Immunohistochemistry; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; Sorafenib | 2009 |
Design and in vitro evaluation of a novel polymeric excipient for buccal applications.
Topics: Administration, Buccal; Animals; Caco-2 Cells; Cell Survival; Chitin; Chitosan; Drug Carriers; Excipients; Hardness; Humans; Niacinamide; Rhodamine 123; Sulfhydryl Compounds; Swine; Tablets; Water | 2013 |